top of page

Search Results

Search results for "Dopamine receptor D3"

Results found for "Dopamine receptor D3"

  • 📰 GPCR Weekly News, April 8 to 14, 2024

    Sexton et al. for their job on Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and the consequences on G protein signalling Melanin-concentrating hormone receptor 1 is discarded by platform for detecting agonistic peptides that are self-secreted by yeast expressing a G-protein-coupled receptor model for understanding and exploiting biased agonism in next-generation medicines G protein-coupled receptors insights into G protein coupling specificity at a class A GPCR Cryo-EM Structure of the Human Amylin 1 Receptor

  • 📰 GPCR Weekly News, July 17 to July 23, 2023

    "Biased Signaling is Structurally Encoded As An Autoproteolysis Event in Adhesion G Protein-Coupled Receptor GPCR Activation and Signaling Atypical Chemokine Receptor 3 'Senses' CXC Chemokine Receptor 4 Activation A corazonin G protein-coupled receptor gene in the tick Ixodes scapularis yields two splice variants, each coding for a specific corazonin receptor. immuno-oncology EP4 receptor antagonist program including DT-9081.

  • 📰 GPCR Weekly News, February 5 to 11, 2024

    GPCRs in Cardiology, Endocrinology, and Taste G protein-coupled receptors driven intestinal glucagon-like Doxorubicin alters G-protein coupled receptor-mediated vasocontraction in rat coronary arteries GPCRs Using Protein Language Models Scaling up Functional Analyses of the G Protein-Coupled Receptor Rhodopsin Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models Industry

  • 📰 GPCR Weekly News, December 4 to 10, 2023

    and Signaling Distinct beta-arrestin coupling and intracellular trafficking of metabotropic glutamate receptor homo- and heterodimers Structural basis of G protein-Coupled receptor CMKLR1 activation and signaling induced by a chemerin-derived agonist Functional profiling of the G protein-coupled receptor C3aR1 reveals GPCRs in Neuroscience Research progress on the role of orphan receptor GPR139 in neuropsychiatric behaviours TRPA1 Expression Is Largely Limited to Sensory Neuron Subsets Orphan peptide and G protein-coupled receptor

  • 📰 GPCR Weekly News, July 31 to August 6, 2023

    Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction The relaxin receptor signals through a mechanism of autoinhibition To probe the activation mechanism of the Delta opioid receptor Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A3 Receptor Expression Pharmacokinetics and Pharmacodynamics of Burixafor Hydrobromide (GPC-100), a Novel C-X-C Chemokine Receptor

  • 📰 GPCR Weekly News

    receptors. Ligand recognition and activation of neuromedin U receptor 2. receptor. Ghrelin receptor signaling in health and disease: a biased view. Substance Use Disorders AbbVie recruits a GPCR team in Oxford, buying out a fledgling biotech for $255M+ Domain

  • Molecular creativity in drug discovery

    Breakthroughs this week:  Orphan receptor GPRC5B in neurogenesis; Septerna’s pill-based weight-loss strategy Must-read publications:  Emerging targets, signaling dynamics, and acid-sensing receptors in disease. Key Insights: • Receptor Localization Matters : Protein complexes pre-assemble at membranes, altering

  • 📰 GPCR Weekly News, May 15 to 21, 2023

    FSLLRY-NH2, a protease-activated receptor 2 (PAR2) antagonist, activates mas-related G protein-coupled receptor C11 (MrgprC11) to induce scratching behaviors in mice. ACE2 Activation by Tripeptide IRW (Ile-Arg-Trp) Depends on the G Protein-Coupled Receptor 30 Signaling and synaptic AMPA receptor endocytosis. Methods & Updates in GPCR Research Computational design of dynamic receptor-peptide signaling complexes

  • 📰 GPCR Weekly News, January 8 to 14, 2024

    Kathleen M Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in January 8th to 14th, 2024 Adhesion GPCRs Conformational transitions and activation of the adhesion receptor CD97 GPCR Activation and Signaling Biased Signaling in Mutated Variants of β2-Adrenergic Receptor: Insights in auditory neurons GPCRs in Oncology and Immunology G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold

  • 📰 GPCR Weekly News, December 11 to 17, 2023

    involves semi-synthetic nanobody-ligand conjugates with enhanced transcriptional outputs at neurokinin receptor GPCR Activation and Signaling GPCR screening reveals that the metabolite receptor HCAR3 regulates epithelial conjugates exhibit tunable signaling properties and enhanced transcriptional outputs at neurokinin receptor governs macrophage migration during tissue inflammation From odor to oncology: non-canonical odorant receptors cancer Methods & Updates in GPCR Research Phosphorylation Sites of the Gastric Inhibitory Polypeptide Receptor

  • 📰 GPCR Weekly News, October 9 to 15, 2023

    and Signaling Diuretic hormone 31 activates two G protein-coupled receptors with differential second components of the Gαi3 heterotrimers Activation/Deactivation Free-Energy Profiles for the β2-Adrenergic Receptor GPCR Binders, Drugs, and more Development of Photoswitchable Tethered Ligands that Target the µ-Opioid Receptor GPCRs in Neuroscience The Drosophila blood-brain barrier regulates sleep via Moody G protein-coupled receptor bioinformatics-based analysis Reviews, GPCRs, and more Parallel evolution of the G protein-coupled receptor

  • Signals in Motion: Pain, Metabolism & Terry’s Corner

    It will bridge foundational receptor theory with today’s most pressing pharmacological questions, from Kenakin   Four decades of receptor theory now fit in one expert-guided hub.

  • Target Residence Time: The Hidden Driver of In Vivo Efficacy

    tissues like tumors slows offset and improves therapeutic window ✅ Examples of how rebinding in dense receptor Diffusion, Rebinding, and Receptor Density: The In Vivo Edge This lecture shows how tissue architecture And when receptors are dense (like GPCRs on membranes), this rebinding hits the collisional limit , where

  • 📰 GPCR Weekly News, January 30 to February 5, 2023

    Cannabinoid 1 (CB1 ) receptor arrestin subtype-selectivity and phosphorylation dependence. Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling Functional expression of oxytocin receptors in pulp-dentin complex. Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands. Cryo-EM structure of orphan G protein-coupled receptor GPR21.

  • Nanobodies: New Dimensions in GPCR Signaling Research

    Nb39: This nanobody was identified for the μ-opioid receptor (μOR) and also increased the affinity of receptor in a ground-state-like. Nanobodies to Study G Protein-Coupled Receptor Structure and Function. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor.

  • The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think

    ATP and sugar monophosphates and the identification of a novel allosteric site on the vasopressin V2 receptor Discover how factors like restricted tissue diffusion and receptor density can dramatically alter drug Learn how fentanyl slows inhalation via opioid receptors, while xylazine prolongs exhalation through alpha-2 adrenergic receptors, creating a synergistic effect that drives overdose deaths.

  • Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024

    Event Spotlight Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Receptors This technique for studying cell receptors could have sweeping implications for drug development DeepCure GPCR Latrophilin-1 controls multiple processes in reproduction of C. elegans The G protein-coupled receptor β-adrenergic signaling Roles of the gate loop in β-arrestin-1 conformational dynamics and phosphorylated receptor DNAJC13 in DOR downregulation GPCRs in Cardiology, Endocrinology, and Taste Role of G protein coupled receptors

  • Unlocking the Therapeutic Potential of Previously Undruggable GPCRs

    Executive Summary This whitepaper will provide an overview of G Protein-Coupled Receptors (GPCRs) and and extracellular faces of the receptor. The other part of the ligand reaches in to contact the TM domain of the receptor, providing a ‘message unchanged and searching for optimized interaction with the TM domain of the receptor. , despite its modest level of receptor internalization activity (Figure 4).

  • From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry

    their mission: to computationally study olfactory GPCRs , a massively under-characterized group of receptors “Choosing one specific receptor is difficult… they’re unique because they can bind many different molecules

  • 📰 GPCR Weekly News

    the extracellular domain provides a path to prolonged agonism in vivo. Quantification of changes in human islet G protein-coupled receptor mRNA expression in obesity. receptor family. Cryo-EM structure of G-protein-coupled receptor GPR17 in complex with inhibitory G protein. Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology.

  • 📰 GPCR Weekly News, March 13 to 19, 2023

    Adhesion GPCRs Crystal Structure of the Extracellular Domains of GPR110. ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference New paradigms in purinergic receptor ligand discovery. G protein-coupled receptor pharmacology - insights from mass spectrometry. Structural basis for motilin and erythromycin recognition by motilin receptor.

  • 📰 GPCR Weekly News, September 18 to 24, 2023

    coupling selectivity of GPCRs Location-biased activation of the proton-sensor GPR65 is uncoupled from receptor Photoactivatable Agonist-Antagonist Pair as a Tool for Precise Spatiotemporal Control of Serotonin Receptor first-in-child use of PRL3-zumab humanized antibody Activation of PI3K/Akt pathway by G protein-coupled receptor identification Reviews, GPCRs, and more The discovery, structure, and function of 5-HTR1E serotonin receptor drug discovery — but only if we give it the right data Inversago Pharma divulges new cannabinoid CB1 receptor

  • 📰 GPCR Weekly News, January 23 to 29, 2023

    GPCR Activation and Signaling A multi-dimensional view of context-dependent G protein-coupled receptor Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex. distinct from the cannabinoid CB1 and CB2 receptors. Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions. Structural and Molecular Determinants for Isoform Bias at Human Histamine H3 Receptor Isoforms.

  • 📰 GPCR Weekly News, June 5 to 11, 2023

    Hexahydroquinoline Derivatives are Selective Agonists for the Adhesion G Protein-Coupled Receptor ADGRG1 Autocrine Proteinase-Activated Receptor (PAR) signaling in PC3 prostate cancer cells. The G protein-coupled receptor neuropeptide receptor-15 modulates larval development via the transforming GPCR Binders, Drugs, and more Adenosine A2A Receptor (A2AAR) Ligand Screening Using the 19F-NMR Probe Stabilization of pre-existing neurotensin receptor conformational states by β-arrestin-1 and the biased

  • How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program

    Breakthroughs this week: Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling; Proximity-Dependent Proteomics Upcoming events:  Get details on the "neuroGPCR" symposium focusing on receptor signaling and a platform down with Alessandro Nicoli, from the Technical University of Munich, to discuss his work on olfactory receptors Discover how breakthroughs like AlphaFold are making previously "undruggable" targets, like olfactory receptors

  • Residency time of agonists does not affect the stability of GPCR-arrestin complexes

    September 2022 "Background and purpose: The interaction of arrestins with G-protein coupled receptors (GPCRs) desensitizes agonist-dependent receptor responses and often leads to receptor internalization The interaction of arrestins with GPCRs requires both agonist activation and receptor phosphorylation the question whether agonists with very slow off-rates can cause the formation of particularly stable receptor-arrestin

  • 📰 GPCR Weekly News, April 24 to 30, 2023

    GPCR Binders, Drugs, and more Allosteric modulation of a human odorant receptor. Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells GPCRs in Cardiology, Endocrinology, and Taste Targeting G Protein-Coupled Receptors for Heart Failure Novel roles for G protein-coupled receptor kinases in cardiac injury and repair. Genetic variants of G-protein coupled receptors associated with pubertal disorders.

  • 📰 GPCR Weekly News, June 19 to 25, 2023

    GPCR Activation and Signaling Stimulation of ectopically expressed muscarinic receptors induces IFN-γ Serotonin 5-HT7 receptor slows down the Gs protein: a single molecule perspective. Striatal mGlu5-mediated synaptic plasticity is independently regulated by location-specific receptor in vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human PAC1 Receptor GPCR Research A coiled-coil-based design strategy for the thermostabilization of G-protein-coupled receptors

  • How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision

    week:  Why Everyone’s Talking About Metabolic GPCRs; GPS for proteins: Tracking the motions of cell receptors Industry insights:  Metabolic GPCRs climbing the spotlight; new tools tracking receptor motion; obesity Must-read publications:  A structural modeling study revealing non-canonical mechanisms of chemokine-driven receptor

  • Pharmacology at Your Fingertips: Terry’s Corner Launches

    GPCR partner Celtarys Research has validated a TR-FRET assay for cannabinoid receptor ligands using their and structure-based analysis reveals how conserved and variable regions across chemokines and their receptors

bottom of page